BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9801305)

  • 1. Construction of a directed hammerhead ribozyme library: towards the identification of optimal target sites for antisense-mediated gene inhibition.
    Pierce ML; Ruffner DE
    Nucleic Acids Res; 1998 Nov; 26(22):5093-101. PubMed ID: 9801305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
    Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
    J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries.
    Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening effective target sites on mRNA: a ribozyme library approach.
    Unwalla HJ; Rossi JJ
    Methods Mol Biol; 2012; 848():329-36. PubMed ID: 22315078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ribozyme that enhances gene suppression in tobacco protoplasts.
    Perriman R; Graf L; Gerlach WL
    Antisense Res Dev; 1993; 3(3):253-63. PubMed ID: 8286926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library.
    Lieber A; Strauss M
    Mol Cell Biol; 1995 Jan; 15(1):540-51. PubMed ID: 7528330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner.
    Pan WH; Xin P; Bui V; Clawson GA
    Mol Ther; 2003 Jan; 7(1):129-39. PubMed ID: 12573626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
    Wiechen K; Zimmer C; Dietel M
    Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.
    Amarzguioui M; Brede G; Babaie E; Grotli M; Sproat B; Prydz H
    Nucleic Acids Res; 2000 Nov; 28(21):4113-24. PubMed ID: 11058107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of adenovirus for high level expression of small RNAs in mammalian cells. Application to a Bcl-2 ribozyme.
    Potter PM; McKenzie PP; Hussain N; Noonberg S; Morton CL; Harris LC
    Mol Biotechnol; 2000 Jun; 15(2):105-14. PubMed ID: 10949823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus.
    Hoeprich S; Zhou Q; Guo S; Shu D; Qi G; Wang Y; Guo P
    Gene Ther; 2003 Aug; 10(15):1258-67. PubMed ID: 12858191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.